Summary
Aims
To estimate Adult
ADHD
Self‐Report Scale (
ASRS
‐v1.1) Symptom Checklist normative total scores among the
US
adult general population and to evaluate overall attention‐deficit hyperactivity disorder (
ADHD
) symptom burden among
US
adults with
ADHD
.
Methods
Prior 2012 and 2013
US
National Health and Wellness Survey respondents were re‐contacted. Demographics, comorbidities, and
ASRS
‐v1.1 data were collected.
ASRS
‐v1.1 scores were compared by sex, age,
ADHD
diagnosis, and
ADHD
medication use. Group differences were evaluated using chi‐square tests and independent samples
t‐
tests for categorical and continuous variables, respectively.
Results
Of 22 397 respondents, 465 self‐reported being diagnosed with
ADHD
by a physician; of these, 174 self‐reported using
ADHD
medication. The mean
ASRS
‐v1.1 total score was 2.0 (
SD
= 3.2); scores differed by age and sex (all,
P
<
0.001).
ADHD
(vs no
ADHD
) was associated with depression (58.1% vs 18.0%), anxiety (53.1% vs 16.0%), and sleep difficulties (37.0% vs 14.0%) (all,
P
<
0.001).
ADHD
medication use (vs no use) was associated with depression (68.4% vs 51.9%), anxiety (67.2% vs 44.7%), panic disorder (25.9% vs 17.2%), and insomnia (27.6% vs 19.6%) (all,
P
<
0.05).
ADHD
(vs no
ADHD
) respondents scored higher on all 18
ASRS
‐v1.1 items (all,
P
<
0.05). Medication users (vs non‐users) scored higher on six items (all,
P
<
0.05).
Discussion
Adult
ADHD
may be undertreated or sub‐optimally treated, despite a high symptom burden. Normative data will allow comparisons with individuals’ scores to support the assessment of
ADHD
symptom burden among adults.
Conclusion
Findings highlight the importance of assessing
ADHD
symptom burden, especially among adults presenting with comorbidities.